• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELG:US

107.0900 USD 0.1500 0.14%

As of 20:10:00 ET on 10/31/2014.

Snapshot for Celgene Corp (CELG)

Open: 108.7400 Day's Range: 106.6744 - 109.2500 Volume: 5,798,073
Previous Close: 106.9400 52wk Range: 66.8500 - 109.2500 1-Yr Rtn: +41.56%

Stock Chart for CELG

No chart data available.
  • CELG:US 107.0300
  • 1D
  • 1M
  • 1Y
106.9400
Interactive CELG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELG

Current P/E Ratio (ttm) 49.2343
Estimated P/E(12/2014) 29.0453
Relative P/E vs. SPX 2.7521
Earnings Per Share (USD) (ttm) 2.1751
Est. EPS (USD) (12/2014) 3.6870
Est. PEG Ratio 1.1379
Market Cap (M USD) 85,533.23
Shares Outstanding (M) 798.70
30 Day Average Volume 5,892,400
Price/Book (mrq) 14.8557
Price/Sale (ttm) 11.7834
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELG

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chairman/CEOMark J AllesPresident/COO
Peter N KelloggExec VP/CFOThomas O DanielExec VP/Pres:Research
More Company Profile & Key Executives for CELG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil